Tuned Raises $2.5M Seed Round to Radically Upend the Status Quo in Hearing Care

Tuned, a hearing health company focused on providing hearing care for all, today announced that it raised $2.5 million in seed funding, led by Idealab NY and Elements Health Ventures.

Following successful pilots with companies such as RetailBound and Mishe, the injection of new capital will be used to scale employer adoption and bring comprehensive hearing wellness to the workforce as a specialty healthcare benefit offering.

Tuned delivers the first and only comprehensive hearing health benefit: employees access specialist audiologists, as well as hundreds of vetted hearing health products, via the Tuned platform. Tuned is also the only benefit offering over-the-counter (OTC) hearing aids and tinnitus management apps, as well as traditional hearing aid and hearing protection options. Tuned empowers employers to offer a new type of benefit tethered to lifelong hearing care, complete with transparent pricing models and enrollment support.

Today, 25% of working-age adults and 15% of school-age children experience hearing issues, from hearing loss to ringing in the ears (Tinnitus), balance issues, Auditory Processing Disorders (APD), and more.

In fact, the recent FDA ruling on OTC hearing aids has shifted the care discussion to working-age adults, but employer-sponsored benefits – how most working U.S. adults receive healthcare coverage – are not yet ready to meet this need. Five Major hearing aid manufacturers currently own many hearing health benefits and audiology clinics, causing them to focus entirely on product sales rather than care.

This control by hearing aid manufacturers has long ignored even mild-to-moderate hearing loss, which can lead to severe health consequences, including social isolation, cognitive fatigue, and depression.

This creates a need for employer-sponsored hearing benefits that provide proper diagnosis and counseling for those living with hearing loss, and other hearing issues.

Undiagnosed hearing issues cost employers $2,200 per person per year, representing a 46% increase in healthcare spending compared to people without hearing loss. A recent survey of more than 350 working-age adults, conducted by Tuned, showed that the pandemic has led to an increase in hearing issues. Findings show that 1/3 of adults wear headphones for up to eight hours per day, which could lead to hearing fatigue and auditory processing issues. In addition, 50% of respondents experience hearing fatigue and notice a decrease in productivity as a result.

“Hearing is as critical as any of the senses in providing people with the ability to work, socialize and connect with others. Despite this, millions of people who are impacted by hearing issues but not ready for a hearing aid receive no care options in their benefits package,” said Danny Aronson, Tuned’s CEO and co-founder. “Tuned is not only providing a patient-centric answer to this care gap, but we’re doing it through employer-sponsored benefits, which is how the majority of Americans receive their healthcare.”

“The stigma against hearing care is partly driven by the current industry landscape and partly by the fact that we don’t discuss hearing in the same way we do for concerns such as vision care and mental health,” said Kate McGinley, Tuned’s Chief Growth Officer and co-founder. “Tuned is committed to breaking down healthcare barriers and helping to prioritize hearing wellness for those in need.”

Tuned is shifting the hearing benefit model away from only severe hearing loss and hearing aids in order to bring hearing health mainstream, and erase the social stigma around one of the most important senses. Tuned’s benefit serves patients of all ages, including children, by connecting Tuned’s specialist Doctors of Audiology with patients via an easy-to-use, clinically validated platform. It offers affordable, convenient, and accessible solutions to employees around the world.

SourceTuned
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

MMI notes the funds will support commercialization of the Symani® Surgical System in high-growth markets and continued investment in studies that generate clinical evidence and enable indication expansion. Investments will also accelerate advanced technology capabilities and enable MMI to scale its operational capabilities globally.
“We are excited to begin our journey as a public company with this additional investment. We believe Tevogen’s patient-centric approach, which merges a focus on affordability with advanced science, is a blueprint for sustainable success in the current era of healthcare. I am pleased that investors now have the opportunity to participate in Tevogen’s mission to become the very first life science company offering commercially attractive and affordable personalized T cell therapies for large patient populations in virology, oncology, and neurology, said the CEO of Tevogen Bio.
MB2 Dental notes the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company's Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.

By using this website you agree to accept Medical Device News Magazine Privacy Policy